BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 10, 2008
View Archived Issues
Nektar Halts Partnership Talks Over Exubera Cancer Concerns
Nektar Therapeutics Inc. said it will cease all spending and partnership talks for Exubera after a new analysis of clinical trial data revealed an increased risk of lung cancer. (BioWorld Today)
Read More
Regenerative Medicine Trying to Get Big Pharma on Board
Read More
Schering-Plough Drops Asentar, Returns All Rights to Novacea
Read More
Neurogen Raising $30.6M to Advance Four Programs
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More